Detalhe da pesquisa
1.
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic-phase CML in clinical practice: 3-year European SIMPLICITY data.
Eur J Haematol
; 106(1): 82-89, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989776